Summary
Stryker Corporation's second-quarter 2019 report (filed July 25, 2019) indicates solid top-line growth, with net sales increasing 9.9% year-over-year to $3.65 billion for the quarter and 9.2% to $7.17 billion for the first six months. This growth was driven by robust unit volume increases across its key segments, particularly Neurotechnology and Spine, and MedSurg. While gross profit margin saw a slight decrease, the company's adjusted operating income margin improved, reflecting effective cost management and operational efficiencies, especially within Selling, General, and Administrative expenses. Despite facing higher recall charges and increased amortization from recent acquisitions, Stryker demonstrated strong operational performance. The company repurchased shares and paid dividends, indicating confidence in its financial position and commitment to shareholder returns. Cash flow from operations remained healthy, although it was lower than the prior year due to working capital changes. The company's balance sheet shows a strong liquidity position with significant current assets exceeding current liabilities.
Financial Highlights
51 data points| Revenue | $3.65B |
| Cost of Revenue | $1.27B |
| Gross Profit | $2.38B |
| R&D Expenses | $246.00M |
| SG&A Expenses | $1.28B |
| Operating Expenses | $1.77B |
| Operating Income | $613.00M |
| Net Income | $480.00M |
| EPS (Basic) | $1.29 |
| EPS (Diluted) | $1.26 |
| Shares Outstanding (Basic) | 373.90M |
| Shares Outstanding (Diluted) | 379.50M |
Key Highlights
- 1Consolidated net sales increased by 9.9% to $3.65 billion for the three months ended June 30, 2019, and by 9.2% to $7.17 billion for the six months ended June 30, 2019.
- 2The Neurotechnology and Spine segment showed the strongest growth, with net sales up 18.9% for the quarter and 19.8% for the year-to-date.
- 3Recall charges significantly increased to $117 million for the quarter, primarily related to hip stem and femoral head recalls, impacting reported operating income.
- 4Amortization of intangible assets rose by 10.9% for the quarter and 11.3% for the six months, largely due to recent acquisitions.
- 5Adjusted net earnings per diluted share increased by 12.5% for the quarter and 12.2% for the six months, demonstrating operational leverage and effective cost control.
- 6The company repaid $1.34 billion in debt during the first six months of 2019 and continued its share repurchase program and dividend payments.
- 7Cash and cash equivalents decreased from $3.62 billion to $1.75 billion, primarily due to debt repayments and acquisitions.